基因组学与应用生物学

参考文献

Borchelt D.R.,1998,Metabo lism of presenilin 1:influence of presenilin 1 on amyloid precursor protein processing,Neurobiology of Aging,19(1):15-18

Brion J.P.,Anderton B.H.,Authelet M.,Dayanandan R.,Leroy K.,Lovestone S.,Octave J.N.,Pradier L.,Touchet N.,and Tremp G.,2001,Neurofibrillary tangles and tau phosphorylation,Biochemical Society Symposium,67(67):81-88

Brown C.M.,Wright E.,Colton C.A.,Sullivan P.M.,Laskowitz D.T.,and Vitek M.P.,2002,Apolipoprotein E isoform mediated regulation of nitric oxide release,Free Radical Biology and Medicine,32(11):1071-1075

Chen Y.,Lomnitski L.,Michaelson D.M.,and Shohami E.,1997Motor and cog nitive deficits in apolipoprotein E-deficient mice after closed head injury,Neuroscience,80(4):1255-1262

Dewachter I.,Van Dorpe J.,Spittaels K.,Tesseur I.,van Den Haute C.,Moechars D.,and Van Leuven F.,2000,Modeling Alzheimer's disease in transgenic mice:effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice,Experimental Gerontology,35(6):831-841

Dewji N.N.,Singer S.J.,Maliah E.,Rockenstein E.,Klm M.,Harber M.,and Horwood T.,2015,Peptides of presenilin-1bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduceβ-amyloid in Alzheimer's disease,PLo S One,10(4):e0122451

Ezra Y.,Oron L.,Moskovich L.,Roses A.D.,Beni S.M.,Shohami E.,and Michaelson D.M.,2003,Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury,Neuroscience,121(2):315-325

Games D.,Adams D.,Alessandrini R.,Barbour R.,Borthelette P.,Blackwell C.,Carr T.,Clemens J.,Donaldson T.,Gillespie F.,Guido T.,Hagopian S.,Johnson W.K.,Khan K.,Lee M.,Leibowitz P.,Lieberburg I.,Little S.,Masliah E.,Mcconlogue L.,Montoya Z.M.,Mucke L.,Paganini L.,Penniman E.,Power M.,Schenk D.,Seubert P.,Snyder B.,Soriano F.,Tan H.,Vitale J.,Wadsworth S.,Wolozin B.,and Zhao J.,1995,Alzheimer-type neuropathology in transgenic mice overexpressing V717F|[beta]|-amyloid precursor protein,Nature,373(6514):523-527

G觟tz J.,Schild A.,Hoerndli F.,and Pennanen L.,2004,Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease:insight from transgenic mouse and tissue-culture models,International Journal of Developmental Neuroscience,22(7):453-465

Holtzman D.M.,Fagan A.M.,Mackey B.,Tenkova T.,Sartorius L.,Paul S.M.,Bales K.,Ashe K.H.,Irizarry M.C.,and Hyman B.T.,2000,Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model,Annals of Neurology,47(6):739-747

Janus C.,Amelio S.D.,Amitay O.,Chishti M.A.,Strome R.,Fraser P.,Carlson G.A.,Roder J.C.,George-Hyslop P.S.,and Westaway D.,2000,Spatial learning in transgenic mice expressing human presenilin 1(PS1)transgenes,Neurobiology of Aging,21(4):541-549

Lewis J.,Dickson D.W.,Lin W.L.,Chisholm L.,Corral A.,Jones G.,Yen S.H.,Sahara N.,Skipper L.,Yager D.,Eckman C.,Hardy J.,Hutton M.,and Mc Gowan E.,2001,Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,Science,293(5534):1487-1491

Lewis J.,Mc Gowan E.,Rockwood J.,Melrose H.,Nacharaju P.,Van Slegtenhorst M.,Gwinn-Hardy K.,Murphy M.P.,Baker M.,Yu X.,Duff K.,Hardy J.,Corral A.,Lin W.L.,Yen S.H.Dickson D.W.,Davies P.,and Hutton M.,2000,Neurofibrillary tangles,amyotrophy and progressive motor disturbance in mice expressing mutant(P301L)tau protein,Nature genetics,25(4):402-405

Liu H.B.,and Wu H.X.,2013,Overview of the pathogenesis and animal models of Alzheimer's disease,Shenjing Yaoli Xuebao(Acta Neuropharmacologica),3(4):14-22(刘红彬,武海霞,2013,阿尔茨海默病发病机制和动物模型研究进展神经药理学报,3(4):14-22)

Oakley H.,Cole S.L.,Logan S.,Maus E.,Shao P.,Craft J.,Guillozet-Bongaarts A.,Ohno M.,Disterhoft J.,Van Eldik L.Berry R.,and Vassar R.,2006,Intraneuronalβ-Amyloid aggregates,neurodegeneration,and neuron loss in transgen-ic mice with five familial Alzheimer's disease mutations:potential factors in amyloid plaque formation,Journa of Neuroscience,26(40):10129-10140

Oddo S.,Caccamo A.,Kitazawa M.,Tseng B.P.,and Laferla FM.,2003,Amyloid deposition precedes tangle formation in a triple transgenic model of alzheimer's disease,Neurobiology of Aging,24(8):1063-1070

Song M.,Tang J.,Li D.B.,Xu H.W.,and Bai Y.,2006,Genetype identification and histologic analysis of PS1/APP double transgenic A lzheimer disease mouse model,Disan Juny Daxue Xuebao(Acta Academiae Medicinae Militaris Tertiae),28(14):1453-1456(宋敏,唐军,李达兵,徐海伟,白云2006,PS1/APP双转基因阿尔茨海默病模型传代小鼠的基因型鉴定及其组织学分析,第三军医大学学报,28(14)1453-1456)

Terwel D.,Dewachter I.,and Van Leuven F.,2002,Axonal transport,tau protein and neurodegeneration in Alzheimer's disease,Neuromolecular Medicine,2(2):151-165

Van den Haute C.,Spittaels K.,Van Dorpe J.,Lasrado R.,Vandezande K.,Laenen I.,Geerts H.,and Van Leuven F.,2001,Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice,Neurobiology of Disease,8(1):32-44

Wang L.L.,Na X.,Zhu X.N.,Chen R.Z.,Wang H.,and Wang X.L.,2012,Generation of Tau/APP/PS1 triple-transgenic mouse model and the study of its biological characteristics,Zhongguo Yingyong Shenglixue Zazhi(Chinese Journal of Applied Physiology),28(4):294-297(王利利,纳鑫,朱小南,陈汝筑,汪海,汪雪兰,2012,Tau/APP/PS1三转基因小鼠模型的建立及生物学特征,中国应用生理学杂志,28(4):294-297)

Xu P.T.,Li Y.J.,Qin X.J.,Scherzer C.R.,Xu H.,Schmechel D.E.,Hulette C.M.,Ervin J.,Gullans S.R.,Haines J.,Pericak-Vance M.A.,and Gilbert J.R.,2006,Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease,Neurobiology of Disease,21(2):256-275

Zhang T.S.,Wang H.Q.,Wang W.Y.,He Y.S.,and Huang S.K.,2006,Relationship between apolipoprotein E,D10S1225polymorphisms and late-onset Alzheimer's disease,Chinese Medical Journal,119(4):294-299

Zhao Y.X.,Su D.S.,Wang X.R.,and Chen J.,2010,Comparison of learning and memory of APPswe/PS1d E9 double transgenic mice model of Alzheimer's disease and wild-type mice,Zhongguo Linchuang Shenjing Kexue(Chinese Journal of Clinical Neurosciences),18(6):561-564(赵燕星,苏殿三,王祥瑞,陈杰,2010,阿尔茨海默病APPswe/PS1d E9双转基因型与野生型小鼠学习记忆能力的比较,中国临床神经科学,18(6):561-564